Brief: Ck Life Sciences Intl (Holdings) Posts Profit For Year Attributable Of Hk$263 Mln
March 19 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* RECOMMENDED A FINAL DIVIDEND OF HK$0.01 PER SHARE
* PROFIT FOR YEAR ATTRIBUTABLE HK$263 MILLION VERSUS
HK$258.4
MILLION
* FY REVENUE HK$5.23 BILLION VERSUS HK$4.69 BILLION
Source text for Eikon: ID:nHKS8l1Zpc
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development